NEWSMAX @NEWSMAX
Pfizer and its German partner BioNTech said that their omicron-adapted COVID-19 vaccine booster generated a strong immune response against the currently circulating BA.5 and the BA.4 subvariants.https://t.co/dVJuHYYta0 — PolitiTweet.org